Global Intravenous (IV) Solution Market is expected to reach USD 11,511.2 million by 2022

Global Intravenous (IV) Solution Market Information, by Type (Total Parenteral Solution, Peripheral Parenteral Solution), by Nutritional Content (Amino Acid Solution, Carbohydrates, Vitamins & Minerals, Parenteral Lipid Emulsion and Others), by End User (Hospitals & Clinics, Ambulatory and Homecare) - Forecast to 2022
Intravenous (IV) Solution are intended to be administered to the patients which are deficient in nutrients or at the time of serious dehydration. These solutions are given to the patients whose fluid volume or body nutrients falls. Many companies manufactures packaged intravenous fluids or products or compounds which can be mixed with sterile water to prepare a solution for intravenous administration. The market for intravenous solutions is growing swiftly.
The market for Intravenous (IV) Solution is expected to reach USD 11,511.2 million by 2022 and is expected to grow at a CAGR of 7.69% during the forecast period 2016-2022. The factors which drive the growth of the market are the rising prevalence of chronic diseases, rising acceptance of vitamin C intravenous treatment therapy to treat colorectal cancer.

sample report available at https://www.marketresearchfuture.com/sample_request/1235 .

Intended Audience
• Intravenous (IV) Solution Manufacturer
• Intravenous (IV) Solution Vendors
• Pharmaceutical & Biotechnology Companies
• Market Research and Consulting Service Providers
Key Finding
• The global Intravenous (IV) Solution market and is expected to reach USD 11,511.2 million by 2022
• By type, Total Parenteral Nutrition (TPN) holds the largest market share of global Intravenous (IV) Solution market and is expected to reach USD 4,940.0 million in 2016
• By nutritional content, amino acid solution holds the largest market share of global Intravenous (IV) Solution market is expected to reach USD 2,385.0 million in 2016
The major participants of this market are
• ICU Medical, Inc. (U.S.)
• B. Braun Melsungen AG (Germany)
• Fresenius Kabi AG (Germany)
• Baxter (U.S.)
• Amanta Healthcare (India)
• Terumo Medical Corporation (Tokyo)
• Grifols S.A. (Spain)

Browse complete report at https://www.marketresearchfuture.com/reports/intravenous-solution-market-1235 .

Global Intravenous (IV) Solution Market has been segmented on the basis of type which comprises of total parenteral solution, peripheral parenteral solution. On the basis of nutritional content the market is segmented into amino acid solution, carbohydrates, vitamins & minerals, parenteral lipid emulsion and others. On the basis of end user the market is segmented into hospitals & clinics, ambulatory and home care.
The global market for Intravenous (IV) Solution is growing rapidly. The market for Intravenous (IV) Solution is growing with the CAGR of 7.69% during the forecast period from 2016-2022. North America accounts for largest market share in 2015 and is expected to reach USD 4,276.5 million in 2016. This growth is attributed to the factors such as high IV consumption number, high prevalence of chronic diseases.
Asia-Pacific region is the fastest growing market for real time health monitoring devices, which is expected to grow at a CAGR of 8.34% during the forecast period from 2016 to 2022 is due to the emergence of high-quality and better healthcare infrastructure and institutions in this region.
The report for Global Intravenous (IV) Solution Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions

Get a discount at https://www.marketresearchfuture.com/check-discount/1235 .

Table of Content
1 Report Prologue 12

2 Introduction 16

2.1 Scope of Study 16

2.2 Research Objective 16

2.3 Assumptions & Limitations 16

2.3.1 Assumptions 16

2.3.2 Limitations 16

2.4 Market Structure 17

3 Research Methodology 18

3.1 Primary Research 19

3.2 Secondary Research 19

4 Market Dynamics 20

4.1 Introduction 20

4.2 Drivers 21

4.2.1 Increasing Prevalence of the Chronic Diseases 21

4.2.2 Rise of Cholera 21

4.2.3 Growing acceptance of vitamin C intravenous for Colorectal Cancer 22

4.3 Restraints 22

4.3.1 Presence of Stringent Government Regulations 22

4.4 Opportunities 22

4.4.1 Rising continuous demand of IV solutions in U.S. 23

4.5 Challenge 23

4.5.1 Increasing Vitamin C Intravenous Therapy Prices 23

4.6 Mega Trends 24

4.7 Macroeconomic Indicators 24

5 Market Factor Analysis 26

5.1 Porters five forces analysis 26

5.1.1 Introduction 26

5.1.2 Bargaining Power of Suppliers 27

5.1.3 Bargaining Power Of Buyers 27

5.1.4 Threat of Substitutes 27

5.1.5 Rivalry 28

5.1.6 Threat of New Entrants 28

5.2 Value chain Analysis 28

5.2.1 Introduction 28

5.2.2 Inputs 28

5.2.3 Research & Development 29

5.2.4 Development Stage 29

5.2.5 Manufacturing process of IV solutions 29

5.2.6 Marketing And Distribution 29

5.3 Demand Supply Gap Analysis 30

5.4 Price factor analysis 31

5.5 Investment Feasibility Analysis 32

6 Global IV Solution Market, By Types 33

6.1 Introduction 33

6.2 Peripheral Parenteral Nutrition 34

6.3 Total Parenteral Nutrition 35

7 Global IV Solution Market, By Nutritional Content 37

7.1 Introduction 37

7.2 Amino Acid Solution 38

7.3 Carbohydrates 39

7.4 Vitamins & minerals 40

7.5 Parenteral lipid emulsion 40

7.6 Other Solutions 41

8 Global IV Solution Market, By End Users 42

8.1 Introduction 42

8.2 Hospital & Clinics 43

8.3 Ambulatory 44

8.4 Home Care 45

9 Global IV Solution Market, By Regions 46

9.1 Introduction 46

9.2 North America 48

9.2.1 US 51

9.2.2 Canada 52

9.3 Europe 54

9.3.1 Germany 57

9.3.2 France 58

9.3.3 Italy 60

9.3.4 UK 61

9.3.5 Spain 63

9.3.6 Rest of Europe 65

9.4 Asia Pacific 67

9.4.1 Japan 70

9.4.2 China 71

9.4.3 India 73

9.4.4 Republic of Korea 74

9.4.5 Australia 76

9.4.6 Rest of Asia Pacific 78

9.5 Middle East & Africa 80

9.5.1 UAE 83

9.5.2 Saudi Arabia 85

9.5.3 Egypt 86

9.5.4 Rest of Middle East & Africa 88

10 Company Share Analysis 90

11 Company Profiles 92

11.1 Baxter 92

11.1.1 Company Overview 92

11.1.2 Product/Business Segment Overview 92

11.1.3 Financial Overview 93

11.1.4 Key Development 95

11.1.5 SWOT Analysis 95

11.2 Fresenius Kabi AG 96

11.2.1 Company Overview 96

11.2.2 Product/Business Segment Overview 96

11.2.3 Financial Overview 97

11.2.4 Key Development 98

11.2.5 SWOT Analysis 99

11.3 Braun Melsungen AG 100

11.3.1 Overview 100

11.3.2 Product/Business Segment Overview 100

11.3.3 Financial Updates 101

11.3.4 Key Development 102

11.3.5 SWOT Analysis 104

11.4 ICU Medical, Inc. 105

11.4.1 Company overview 105

11.4.2 Product Overview 105

11.4.3 Financials 106

11.4.4 Key Developments 107

11.4.5 SWOT Analysis 108

11.5 Grifols S.A 109

11.5.1 Company Overview 109

11.5.2 Product Overview 109

11.5.3 Financial Overview 110

11.5.4 Key Development 111

11.5.5 SWOT Analysis 112

11.6 Terumo Medical Corporation 113

11.6.1 Company Overview 113

11.6.2 Product Overview 113

11.6.3 Financial Overview 114

11.6.4 Key Developments 115

11.6.5 SWOT Analysis 116

11.7 Amanta Healthcare 117

11.7.1 Company Overview 117

11.7.2 Product Overview 117

11.7.3 Financial Overview 118

12 MRFR Conclusion 119

12.1 Key Findings 119

12.1.1 From CEO’s View Point 119

12.1.2 Unmet Needs 119

12.2 Key companies to watch 119

13 APPENDIX 120

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Akash Anand
P: +1 646 845 9312
W: www.marketresearchfuture.com

This release was published on openPR.